New PERSIMUNE publicationCancer-chemotherapy induced febrile neutropenia: First report from PERSIMUNE on this topic by Nordvig et al, suggesting that the development of febrile neutropenia identifies
a subgroup of those treated with persistent vulnerability to contract subsequent serious infections. Get the article here
Aagaard et al has developed algorithms able to reliable patients at risk of febrile neutropenia – in press. Future research efforts to better understand the biological mechanisms explaining the vulnerability are required.